We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.
- Authors
Twelves, C; Scheithauer, W; McKendrick, J; Seitz, J-F; Van Hazel, G; Wong, A; Díaz-Rubio, E; Gilberg, F; Cassidy, J
- Abstract
This multicenter randomized trial compared oral capecitabine with bolus i.v. 5-fluorouracil (5-FU)/folinic acid (FA) as adjuvant therapy for stage III colon cancer.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 5, p1190
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdr366